Stock Scorecard



Stock Summary for SI-BONE Inc (SIBN) - $12.15 as of 11/20/2024 8:42:16 PM EST

Total Score

12 out of 30

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for SIBN

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for SIBN

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for SIBN

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for SIBN

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for SIBN (29 out of 90)

Stock Price Rating (Max of 10) 5
Historical Stock Price Rating (Max of 10) 7
Stock Price Trend (Max of 10) 1
Book Value (Max of 10) 3
Book Value to Price (Max of 10) 0
Analyst Buy Ratings (Max of 5) 5
Analyst Strong Buy Ratings (Max of 5) 4
Dividend Yield Percentage (Max of 10) 0
Operating Margin (Max of 10) 0
Trading Volume (Max of 10) 4
Price to Earnings (Max of 10) 0

Latest News for for SIBN

SI-BONE To Present at Piper Sandler 36th Annual Healthcare Conference on December 4, 2024 11/20/2024 9:09:00 PM
SI-BONE To Present at Piper Sandler 36th Annual Healthcare Conference on December 4, 2024 - SI-BONE ( NASDAQ:SIBN ) 11/20/2024 9:09:00 PM
Si-Bone ( SIBN ) Reports Q3 Loss, Lags Revenue Estimates 11/12/2024 10:25:00 PM
Nuwellis, Inc. ( NUWE ) Q3 Earnings Surpass Estimates 11/11/2024 2:15:00 PM
Artivion ( AORT ) Tops Q3 Earnings and Revenue Estimates 11/7/2024 11:05:00 PM
Steris ( STE ) Surpasses Q2 Earnings Estimates 11/6/2024 10:45:00 PM
SI-BONE Receives Transitional Pass-Through Payment Status for iFuse Bedrock Granite™ - SI-BONE ( NASDAQ:SIBN ) 11/5/2024 1:30:00 PM
Strength Seen in Si-Bone ( SIBN ) : Can Its 6.9% Jump Turn into More Strength? 10/30/2024 7:35:00 AM
SI-BONE To Report Third Quarter 2024 Financial Results on November 12, 2024 10/22/2024 8:09:00 PM
SI-BONE To Report Third Quarter 2024 Financial Results on November 12, 2024 - SI-BONE ( NASDAQ:SIBN ) 10/22/2024 8:09:00 PM

Financial Details for SIBN

Company Overview

Ticker SIBN
Company Name SI-BONE Inc
Country USA
Description SI-BONE, Inc., a medical device company, develops implantable devices used in the surgical treatment of the sacropelvic anatomy in the United States and internationally. The company is headquartered in Santa Clara, California.
Sector Name LIFE SCIENCES
Industry Name SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Most Recent Quarter 9/30/2024
Next Earnings Date N/A

Stock Price History

Last Day Price 12.15
Price 4 Years Ago 29.90
Last Day Price Updated 11/20/2024 8:42:16 PM EST
Last Day Volume 217,144
Average Daily Volume 444,528
52-Week High 21.70
52-Week Low 11.76
Last Price to 52 Week Low 3.32%

Valuation Measures

Trailing PE N/A
Industry PE 52.46
Sector PE 40.32
5-Year Average PE -16.05
Free Cash Flow Ratio 3.47
Industry Free Cash Flow Ratio 35.05
Sector Free Cash Flow Ratio 27.97
Current Ratio Most Recent Quarter 8.25
Total Cash Per Share 3.50
Book Value Per Share Most Recent Quarter 3.95
Price to Book Ratio 3.28
Industry Price to Book Ratio 5.44
Sector Price to Book Ratio 20.88
Price to Sales Ratio Twelve Trailing Months 3.30
Industry Price to Sales Ratio Twelve Trailing Months 13.48
Sector Price to Sales Ratio Twelve Trailing Months 7.11
Analyst Buy Ratings 5
Analyst Strong Buy Ratings 4

Share Statistics

Total Shares Outstanding 41,938,200
Market Capitalization 509,549,130
Institutional Ownership N/A

Dividends

Ex-Dividend Date N/A
Last Dividend Amount 0.00
Current Dividend Amount 0.00
Total Years Dividend Increasing N/A
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY 0.00%
Annual Earnings Growth 29.25%
Reported EPS 12 Trailing Months -0.91
Reported EPS Past Year -0.65
Reported EPS Prior Year -1.14
Net Income Twelve Trailing Months -37,401,000
Net Income Past Year -43,336,000
Net Income Prior Year -61,256,000
Quarterly Revenue Growth YOY 18.60%
5-Year Revenue Growth 19.35%
Operating Margin Twelve Trailing Months -0.19

Balance Sheet

Total Cash Most Recent Quarter 146,757,000
Total Cash Past Year 156,079,000
Total Cash Prior Year 84,575,000
Net Cash Position Most Recent Quarter 110,565,000
Net Cash Position Past Year 120,014,000
Long Term Debt Past Year 36,065,000
Long Term Debt Prior Year 35,171,000
Total Debt Most Recent Quarter 36,192,000
Equity to Debt Ratio Past Year 0.82
Equity to Debt Ratio Most Recent Quarter 0.82
Total Stockholder Equity Past Year 169,375,000
Total Stockholder Equity Prior Year 98,302,000
Total Stockholder Equity Most Recent Quarter 164,974,000

Free Cash Flow

Free Cash Flow Twelve Trailing Months -25,224,000
Free Cash Flow Per Share Twelve Trailing Months -0.60
Free Cash Flow Past Year -26,512,000
Free Cash Flow Prior Year -51,162,000

Options

Put/Call Ratio 0.00
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD 0.21
MACD Signal 0.14
20-Day Bollinger Lower Band 11.89
20-Day Bollinger Middle Band 14.58
20-Day Bollinger Upper Band 17.26
Beta 1.23
RSI 43.87
50-Day SMA 16.06
150-Day SMA 17.93
200-Day SMA 20.35

System

Modified 11/19/2024 12:33:57 PM EST